1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with 4-chloro-7-nitrobenzofurazan in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boldin, S; Futerman, AH | 1 |
Fujisawa, T; Hayakawa, T; Ishii, K; Ishitsuka, R; Ito, K; Kobayashi, T; Makino, A; Matsuo, H; Murate, M; Suzuki, M; Suzuki, Y | 1 |
Cabot, MC; Gupta, V; Jazwinski, SM; Liu, YY; Patwardhan, GA; Zhang, QJ | 1 |
3 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and 4-chloro-7-nitrobenzofurazan
Article | Year |
---|---|
Glucosylceramide synthesis is required for basic fibroblast growth factor and laminin to stimulate axonal growth.
Topics: 4-Chloro-7-nitrobenzofurazan; Antineoplastic Agents; Axons; Carboxylic Acids; Cell Polarity; Cells, Cultured; Ceramides; Fibroblast Growth Factor 2; Fumonisins; Glucosylceramides; Hippocampus; Laminin; Morpholines; Neurons; Polylysine; Stereoisomerism; Teratogens | 1997 |
D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol alters cellular cholesterol homeostasis by modulating the endosome lipid domains.
Topics: 1-Deoxynojirimycin; 4-Chloro-7-nitrobenzofurazan; Cells, Cultured; Ceramides; Cholesterol; Endosomes; Enzyme Activation; Fibroblasts; Glucosyltransferases; Homeostasis; Humans; Lipase; Lysophospholipids; Membrane Microdomains; Monoglycerides; Morpholines; Neuroblastoma; Paclitaxel; Stereoisomerism; Sterol Esterase | 2006 |
Direct quantitative determination of ceramide glycosylation in vivo: a new approach to evaluate cellular enzyme activity of glucosylceramide synthase.
Topics: 4-Chloro-7-nitrobenzofurazan; Animals; Cell Line, Tumor; Cell Membrane Permeability; Ceramides; Chromatography, Thin Layer; Colonic Neoplasms; Enzyme Assays; Enzyme Inhibitors; Female; Glucosyltransferases; Glycosylation; Humans; Injections, Intralesional; Mice; Mice, Nude; Morpholines; Oligonucleotides; Ovarian Neoplasms; Random Allocation; Reproducibility of Results; Xenograft Model Antitumor Assays | 2010 |